The Single Use System in Biopharma Manufacturing market has witnessed significant transformation, driven by increasing demand for flexible, contamination-free biopharmaceutical production. This market is pivotal for advancing bioprocessing technologies and meeting stringent regulatory standards, making it a core focus of recent industry growth strategies and market analysis.
Market Size and Overview
The global single use system in biopharma manufacturing market was valued at US$ 7,030.0 Mn in 2021 and is forecast to reach value of US$ 26,450.3 Mn by 2028 at a CAGR of 20.8% between 2022 and 2028.
Single Use System In Biopharma Manufacturing Market Forecast reflects increasing adoption of single-use technologies to improve efficiency, reduce contamination risks, and lower capital expenditures in biopharma manufacturing. Market insights suggest growing biopharmaceutical R&D activities and capacity expansions are key contributors to rising market revenue and industry size, positioning this sector for robust business growth.
Market Drivers
- Rising Biopharmaceutical Production Complexity: One key market driver is the increasing complexity and volume of biologics production, propelling demand for single use systems. For example, in 2024, several leading biopharma companies reported over 25% production capacity expansion using single use solutions, leading to enhanced process flexibility and reduced turnaround times. This driver significantly influences market dynamics by enabling scalable and contamination-free manufacturing processes aligned with evolving regulatory requirements.
PEST Analysis
- Political: Government initiatives to support biopharma infrastructure, such as the FDA’s increasing emphasis on continuous manufacturing and single-use technologies in 2024, are enhancing market opportunities and encouraging investments.
- Economic: Post-pandemic recovery and rising healthcare expenditures globally have increased funding for biologics manufacturing, thus boosting industry size and market revenue in 2025.
- Social: Growing patient demand for biologic therapies, especially in oncology and autoimmune diseases, is intensifying the demand for scalable and safe manufacturing solutions. Public trust in biologics and personalized medicine fosters positive market trends and opportunities.
- Technological: Advances in single use materials and sensors in 2025 have improved system reliability and integration with automation, further expanding the market scope and enhancing market growth strategies among manufacturers.
Promotion and Marketing Initiative
Biopharma equipment providers have intensified efforts to promote single use systems through partnerships and educational campaigns. For instance, in 2024, ThermoFisher Scientific launched a comprehensive marketing initiative highlighting case studies showcasing reduced contamination risks and cost efficiencies, which led to a 15% increase in product inquiries and contributed to overall market growth. Such targeted promotion aids in overcoming market challenges related to technology adoption and accelerates business growth by educating stakeholders on system benefits.
Key Players
Significant market players in the Single Use System in Biopharma Manufacturing market include:
- Getinge AB
- Rentschler Biopharma SE
- Kühner AG
- Danaher Corporation
- Merck KGaA
- Lonza
- PBS Biotech Inc.
- ThermoFisher Scientific
- Corning Incorporated
- Eppendorf
- Pall Corporation
- Entegris
- Sartorius AG (Sartorius Stedim Biotech)
Recent strategies in 2024 and 2025 incorporate:
- Sartorius AG expanding bioprocessing capacities through advanced single use product launches, boosting market revenue significantly in Q2 2025.
- Merck KGaA establishing strategic partnerships with contract development and manufacturing organizations (CDMOs) to enhance market share in Asia-Pacific.
- Danaher Corporation acquiring innovative single use technology startups in 2024, augmenting its product portfolio and accelerating market growth.
These actions confirm that market players continually adapt growth strategies to capitalize on evolving industry trends and market opportunities.
FAQs
1. Who are the dominant players in the Single Use System in Biopharma Manufacturing market?
Dominant market players include Getinge AB, Danaher Corporation, Merck KGaA, Sartorius AG, and ThermoFisher Scientific, all of whom have engaged in expansions, partnerships, and product innovation between 2024 and 2025 to strengthen their market presence.
2. What will be the size of the Single Use System in Biopharma Manufacturing market in the coming years?
The market is projected to grow from USD 7,030.0 million in 2025 to approximately USD 26,450.3 million by 2032, with a CAGR of 20% due to rising adoption and technological advancements.
3. Which end-user industry has the largest growth opportunity?
The biopharmaceutical industry focused on oncology and autoimmune treatments offers the largest growth opportunities, driven by increasing biologic drug demand and production scale-up utilizing single use systems.
4. How will market development trends evolve over the next five years?
Market trends will likely include greater integration of automation with single use technologies, enhanced contamination control, and flexible manufacturing capabilities, all enabling faster product launches and reducing capital expenditure.
5. What is the nature of the competitive landscape and challenges in the Single Use System in Biopharma Manufacturing market?
The market is competitive with key players emphasizing mergers, acquisitions, and technological innovation. Challenges include high initial setup costs and regulatory compliance hurdles, which companies are addressing via strategic marketing initiatives and partnerships.
6. What go-to-market strategies are commonly adopted in the Single Use System in Biopharma Manufacturing market?
Common strategies include collaborations with biopharma companies, participation in industry consortiums, comprehensive education campaigns on single use benefits, and flexible financing options to ease adoption barriers.
Get More Insights on Single Use System In Biopharma Manufacturing Market
Get This Report in Japanese Language –
Get This Report in Korean Language –
Read More Articles Related to this Industry –
Nanofiber Applications in Medical Devices: Revolutionizing Healthcare
Camera Modules in Medical Devices: Revolutionizing Diagnostics and Treatment
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
Comments
0 comment